MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $25,395,220 | +25.2% | 1,095,566 | +25.4% | 0.03% | +20.0% |
Q1 2023 | $20,287,642 | +465106.2% | 873,338 | +190.6% | 0.02% | +316.7% |
Q4 2022 | $4,361 | -99.9% | 300,560 | +35.6% | 0.01% | 0.0% |
Q3 2022 | $4,230,000 | +34.2% | 221,679 | +27.8% | 0.01% | +50.0% |
Q2 2022 | $3,151,000 | -23.2% | 173,410 | +6.5% | 0.00% | -20.0% |
Q1 2022 | $4,102,000 | -10.9% | 162,795 | -2.4% | 0.01% | 0.0% |
Q4 2021 | $4,602,000 | -29.2% | 166,734 | -17.2% | 0.01% | -28.6% |
Q3 2021 | $6,502,000 | – | 201,376 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |